MACQUARIE GROUP LTD - NEOLEUKIN THERAPEUTICS INC ownership

NEOLEUKIN THERAPEUTICS INC's ticker is NLTX and the CUSIP is 64049K104. A total of 86 filers reported holding NEOLEUKIN THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.93 and the average weighting 0.1%.

Quarter-by-quarter ownership
MACQUARIE GROUP LTD ownership history of NEOLEUKIN THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$86,000
+1620.0%
11,960
+2208.9%
0.00%
Q2 2021$5,000
-16.7%
5180.0%0.00%
Q1 2021$6,000
-45.5%
518
-32.2%
0.00%
Q4 2020$11,000
+22.2%
7640.0%0.00%
Q3 2020$9,000
-30.8%
7640.0%0.00%
Q2 2020$13,000
-79.4%
764
-86.3%
0.00%
Q1 2020$63,0005,5710.00%
Other shareholders
NEOLEUKIN THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Opaleye Management Inc. 1,386,300$19,547,0002.55%
EcoR1 Capital, LLC 3,122,704$44,030,0002.37%
Redmile Group, LLC 4,131,869$58,259,0000.70%
Boxer Capital, LLC 1,501,058$21,165,0000.68%
HighVista Strategies LLC 69,727$983,0000.63%
Baker Brothers Advisors 3,821,740$53,887,0000.20%
Highland Private Wealth Management 93,998$1,326,0000.12%
Sio Capital Management, LLC 38,312$540,0000.11%
Point72 Asset Management, L.P. 1,195,725$16,860,0000.08%
Granahan Investment Management 246,299$3,473,0000.08%
View complete list of NEOLEUKIN THERAPEUTICS INC shareholders